Methods of pharmacological treatment of benign prostatic hyperplasia in dogs: An update

被引：0

作者：

Pasikowska, Joanna ^{[1
]}

Nizanski, Wojciech ^{[1
]}

机构：

[1] Uniwersytet Przyrodniczy Wroclawiu, Wydzial Med Weterynaryjnej, Katedra Rozrodu Klin Zwierzat Gospodarskich, PL-50366 Wroclaw, Poland

来源：

MEDYCYNA WETERYNARYJNA-VETERINARY MEDICINE-SCIENCE AND PRACTICE | 2015年 / 71卷 / 06期

关键词：

benign prostatic hyperplasia; dogs; GnRH analogues; GnRH antagonists; antiandrogens; OSATERONE ACETATE; SEMEN QUALITY; HORMONE; GROWTH; DESENSITIZATION; HYPERTROPHY; DELMADINONE; REGRESSION; RECEPTOR; VOLUME;

D O I：

暂无

中图分类号：

S85 [动物医学（兽医学）];

学科分类号：

0906 ;

摘要：

Benign prostatic hyperplasia (BPH) is the most common disease of the prostate in dogs. It can be treated by surgical or pharmacological methods. Surgical methods are used in non-breeder males or males with pathological changes in the testis. Pharmacological treatment is an alternative for breeder males and old animals with associated diseases. Substances that can be used for medical treatment are GnRH analogues, GnRH antagonists, estrogens, progestogens, antiandrogens, inhibitors of 5 alpha-reductase, antiestrogens, and VDR agonists. This paper presents short characteristics of pharmacological substances that we have used in BPH treatment.

引用

收藏

页码：335 / 340

页数：6

相关论文

共 50 条

[31] LASER TREATMENT OF BENIGN PROSTATIC HYPERPLASIA [J].

MUSCHTER, R ;

HOFSTETTER, A .

UROLOGE-AUSGABE A, 1994, 33 (04) :281-287

[32] Phytotherapy in the treatment of benign prostatic hyperplasia [J].

Bracher, F .

UROLOGE-AUSGABE A, 1997, 36 (01) :10-17

[33] Dutasteride for the treatment of benign prostatic hyperplasia [J].

Wu, Christopher ;

Kapoor, Anil .

EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (10) :1399-1408

[34] Options for the Treatment of Benign Prostatic Hyperplasia [J].

Plante, Mark ;

Wachterman, Jared ;

Perrapato, Scott .

CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2012, 22 (04) :281-287

[35] Tadalafil for the treatment of benign prostatic hyperplasia [J].

Monica, Fabiola Zakia ;

De Nucci, Gilberto .

EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (08) :929-937

[36] Association of the Benign Prostatic Hyperplasia and erectile dysfunction, the current treatment modalities in Benign Prostatic Hyperplasia [J].

Sen, Volkan ;

Demir, Omer ;

Esen, Ahmet Adil .

UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2011, 10 (04) :62-64

[37] COMPARATIVE ASSAY OF SEMINAL-PLASMA PROTEINS IN HEALTHY DOGS AND DOGS WITH BENIGN PROSTATIC HYPERPLASIA [J].

Gradinarska, Desislava ;

Ivanova, Maria ;

Genov, Miroslav ;

Tsvetkov, Tsvetan ;

Daskalova, Denica .

COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2019, 72 (08) :1137-1143

[38] Testosterone and benign prostatic hyperplasia [J].

Jarvis, Thomas R. ;

Chughtai, Bilal ;

Kaplan, Steven A. .

ASIAN JOURNAL OF ANDROLOGY, 2015, 17 (02) :212-216

[39] Comparative Evaluation of Diagnostic Methods for Subclinical Benign Prostatic Hyperplasia in Intact Breeding Male Dogs [J].

Laurusevicius, Tomas ;

Siugzdaite, Jurate ;

Juodziukyniene, Nomeda ;

Kerziene, Sigita ;

Anskiene, Lina ;

Jackute, Vaiva ;

Trumbeckas, Darius ;

Van Soom, Ann ;

Posastiuc, Florin Petrisor ;

Zilinskas, Henrikas .

ANIMALS, 2024, 14 (08)

[40] Assessment of the utility of platelet indices to diagnose clinical benign prostatic hyperplasia in dogs [J].

Hosseinpour, Hediyeh ;

Ahmadi-hamedani, Mahmood ;

Masoudifard, Majid ;

Shirani, Darush ;

Narenj Sani, Reza .

FRONTIERS IN VETERINARY SCIENCE, 2022, 9

← 1 2 3 4 5 →